Clarity Pharmaceuticals (CLRPF, $2.86) lost -4 over the last three months. By comparison, the broader Biotechnology Industry returned over the same period. A.I.dvisor analyzed 861 stocks in the Biotechnology Industry over the last three months, and found that of them () exhibited an Uptrend while of them () experienced a Downtrend.